Medical Oncology

Endometrial Cancer   

Questions discussed in this category



Would you consider adjuvant chemotherapy, radiation therapy, hormone therapy, or surveillance?

The patient has a history of pelvic radiation and progressed through first line carboplatin/taxol. She has had a partial response to pembro/lenvatinib...

This case involves an impressive ‘high volume’ vaginal recurrence and patient was not originally planned for adjuvant therapy. Concerned t...

Since no data exists or is pending, and the two disease processes are similar, should we consider PARP inhibition in this setting? This is assumi...

The NCCN recommends either systemic therapy + brachytherapy or pelvic RT + brachy or brachy alone or observation. How do you decide among these option...

Given the recent press release regarding the update on the phase 3 soft tissue sarcoma study of LARTRUVO (olaratumab) showing no benefit to the combin...

Would you approach this situation as synchronous primaries (eg. FIGO IA in both) or as a locally advanced endometrial cancer (FIGO IIIA)? What adjuva...


Papers discussed in this category


The New England journal of medicine, 2019-06-13

Lancet Oncol., 2019 Jul 22

Gynecol Oncol, 2019 Sep

Cancer, 1987-10-15

Gynecologic oncology, 2015-09

Gynecologic oncology, 2014-11

Gynecologic oncology, 2018-10

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018-07-10

Nature, 2013-05-02

Gynecologic oncology, 2019-09

F1000Res, 2019 Jun 12

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019-07-20

Lancet Oncol., 2018 Feb 12

Lancet, 2010-03-06

Lancet,

Gynecol Oncol Rep, 2020 Jan 30

World J Surg Oncol, 2017 Jan 10